Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.02 -0.23%   SPY: 166.74 -0.12%
Discuss Index Tracked By  


  Track the *RXGEN Index  

Generic Drug Stocks (*RXGEN)

  Generic Drug Ideas       Generic Drug Performance       Generic Drug Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
TEVA, NVS, MYL
TEVA, FRX, RDY
NVS, TEVA, PRGO
NVS, TEVA, ACT
 
Index Description: These firms have significant exposure to the generic side of the pharmaceutical industry, focusing on making generic versions of off-patent medications
     
Today:
1-month:
All-time:
-0.3%
+6.2%
+90.5%
vs S&P 500:
vs S&P 500:
vs S&P 500:
-0.2%
-1.0%
+69.8%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$24.9B
29.4
0.5%
     
180 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 ACT $126.87 -0.28 -0.2% 816,827 141% $16.2B - 87% -3% 3 Alerts (1 News) - View
 CPRX $0.89 +0.03 +2.9% 119,478 32% $35.8M - 141% -61% 1 Alert (0 News) - View
 FRX $37.82 -0.16 -0.4% 115,413 30% $10.1B - 21% -3% 3 Alerts (3 News) - View
 HITK $33.18 +0.23 +0.7% 7,525 51% $446.9M - 21% -13% No Alerts/News
 MNTA $12.82 -0.05 -0.4% 60,744 68% $668.2M - 28% -25% No Alerts/News
 MYL $31.14 -0.14 -0.5% 788,091 47% $11.9B - 52% -2% 4 Alerts (2 News) - View
 NVS $73.92 -0.24 -0.3% 282,687 65% $182.2B 2.8% 44% -2% 1 Alert (0 News) - View
 PRGO $118.18 -0.85 -0.7% 56,674 40% $11.1B 0.3% 20% -3% No Alerts/News
 RDY $36.73 -0.93 -2.5% 73,231 101% $6.3B 0.6% 35% -5% No Alerts/News
 SGNT $16.95 +0.33 +2.0% 13,642 66% $467.7M - 34% -15% No Alerts/News
 TEVA $39.98 -0.21 -0.5% 801,071 69% $34.2B 2.4% 9% -7% 1 Alert (1 News) - View
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Is There a Pill For That? Forest Labs’ Iffy Pipeline
FRX  JNJ  AMGN  PJC  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 21, 09:27AM from (ycharts.com)
Forest Labs (FRX) has launched several new products in the past two years – yet has demonstrated limited success in filling  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva Bets on Reformulating Old Drugs as Investors Say 'Show Me'
BMY  FRX  LLY  JNJ  BIIB  ALXA  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 21, 07:01AM from (www.bloomberg.com)
Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts’ highest-rated stock among the world’s  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pharma M&A – Actavis to Acquire Warner Chilcott
FRX  MYL  TEVA  ACT  VRX  WCRX  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com)
On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal
MYL  VRX  WCRX  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com)
Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
US Stocks Fluctuate on Manufacturing, Housing Reports
AMD  CSCO  ACT  TSLA  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 10:37AM from (www.bloomberg.com)
U.S. stock futures were little changed after the Standard & Poor’s 500 Index extended a record yesterday, and before  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva US Jump Widens Holiday Discount: Israel Overnight
TEVA  ACT  WCRX  MLNX  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 15, 11:37PM from (www.bloomberg.com)
Teva Pharmaceutical Industries Ltd. (TEVA) resumes trading today in Tel Aviv (TEVA) at the biggest discount to New York in  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sanofi Fined $52.8 Million for Denigrating Plavix Copies
TEVA  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 06:50AM from (www.bloomberg.com)
Sanofi (SAN), France’s largest drugmaker, was fined 40.6 million euros ($52.8 million) by the country’s competition regulator  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Dr. Reddy’s Q4 & FY13 Financial Results
RDY  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 06:08AM from (www.businesswire.com)
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the fourth quarter  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Israel Joins Rate Cut Club; ETF Doesn't Care And Falls
TEVA  EIS  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 13, 12:08PM from (www.benzinga.com)
From Brussels to Sydney to Hanoi, global central banks have been taking the ax to interest rates over the past several weeks.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Wrap for Friday, May 10: Stocks Gain on Late Day Rally
SPY  ACT  PANL  CALL  WCRX  UUP  TSLA  MCP  RH  TLT  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 04:15PM from (www.benzinga.com)
It was another quiet day on Wall Street, but an afternoon rally pushed the U.S. stock market firmly into positive territory by the closing bell.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Closing Bell for Friday on Wall Street: Markets Open Mixed, Close Higher
BA  LTD  HL  ACT  CALL  UEPS  NVDA  PCLN  TST  DNDN  AFFY  SLW  WCRX  AWK  MCP  WDAY  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 10, 04:07PM from (247wallst.com)
U.S. equity markets opened mixed this morning and failed to find a direction driver throughout the trading day. In Europe,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Adasuve Deal Is Very Good For Alexza, But What About Teva?
BMY  LLY  TEVA  VRX  ALXA  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 09, 04:45PM from (www.investopedia.com)
Teva's partnership with Alexza looks like an expensive gamble.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
MNTA  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 04:43PM from (globenewswire.com)
CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More
BNS  UL  TEVA  TOT  AZN  PSO  TD  UBS  SNY  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 09, 08:35AM from (247wallst.com)
Total return is always the name of the game when it comes to investing success. Stocks that pay dividends on a regular basis  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure
FRX  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 06:00AM from (www.businesswire.com)
Trevena Inc., (Trevena) a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amgen Chased By The Bubble
ABT  PFE  MRK  AMGN  NVO  CELG  TEVA  BIIB  GILD  SNY  AFFY  HSP  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 08, 11:00AM from (www.investopedia.com)
Amgen really needs the pipeline to come through to support this valuation.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.
TEVA  ALXA  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 08, 08:30AM from (www.businesswire.com)
Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Perrigo Reports Record Revenue and Adjusted Earnings
PRGO  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 07, 07:43AM

ALLEGAN, Mich., May 7, 2013 /PRNewswire/ -- Perrigo Company  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion
ABT  LLY  JNJ  AMGN  TEVA  AZN  GSK  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 06, 10:45AM from (247wallst.com)
The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sagent Pharmaceuticals Reports First Quarter 2013 Financial Results
SGNT  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 06, 07:13AM from (globenewswire.com)
SCHAUMBURG, Ill., May 6, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 97



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Generic Drug Stocks Index (*RXGEN).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments